CATEGORIES: Awareness | CMT Update

New Strategic Alliance with Rare Disease Report (RDR)

by | May 27, 2015 | 3 comments

rdrWe are excited to announce our new collaboration with Rare Disease Report (RDR) to increase awareness of Charcot-Marie-Tooth (CMT) among the medical community. RDR’s website, e-newsletter, and print publication offers an independent voice for the Rare Disease Community. They strive to bring together medical, scientific, investment, regulatory, and advocate professionals interested in rare diseases and orphan drugs. Since HNF is focused on supporting and developing treatment options for CMT, this collaboration can be groundbreaking towards advancing CMT disease awareness.

Through this new alliance, HNF will expand its outreach to support our new Health Care Provider (HCP) education program, an initiative aimed at identifying expert HCP’s to support the CMT Patient Community. This program provides clinicians with additional tools to care for their patients such as best standard of practice guidelines, information on genetic testing, and patient assistance programs. In addition, HNF preferred HCP’s gain access to other preferred HNF CMT Providers to support the need for accurate diagnosis, supportive treatments, and other educational materials.

With the help of RDR, we will reach an audience of over 60,000 clinicians through their digital and print distribution channels. Throughout the year, RDR will produce video interviews with CMT experts and industry leaders on the diagnosis and management of patients with CMT, as well as provide insight about new research and clinical trials.

James Radke, PhD, Managing Editor of RDR said, “The rare disease community functions best when all parties are part of the conversation. We look forward to working with HNF and provide them with a means to expand their reach into the clinical population.” Click here to view the HNF-RDR Partnership webpage.

As HNF’s Founder & CEO, I firmly believe that it is clear that HCP’s are unaware of CMT, how to recognize the early symptoms, and how to manage this and related inherited neuropathies. HNF plans to change that!

Finally, HNF is asking the community to please reach out via email at [email protected] and share the HCP’s you would like us to be made aware of and why you would like to see them as part of the HCP directory. Please provide name, address, and phone number.

Learn more on this topic

Related Blog Posts

Double Your Donation

Corporate matching gift programs are charitable giving programs setup by corporations in which the company matches donations made by employees to eligible nonprofit organizations. For example, if a donor works for Bank of America and donates $100 to the Hereditary Neuropathy Foundation, Bank of America will double the donation by also writing a check for $100.

Taking Matters Into Your Own Hands

Do you have a rare form of CMT?

We were contacted recently from a patient with CMT2D who was looking for advice on how to make a difference. Our recommendations for all people with an ultra-rare form of CMT who want to get involved:

Now GRIN is Accessible in 141 Different Languages!

Now GRIN is Accessible in 141 Different Languages!

The Global Registry for Inherited Neuropathies (GRIN) has implemented Google Translate. Why did we choose Google? Because Google is leading the way in teaching computers how to interpret meaning, avoiding the traditional method of decoding language.

Accelerating Patient Access to Investigational Drugs in 2015

Accelerating Patient Access to Investigational Drugs in 2015

Currently the FDA is working to update the process for physicians applying for accelerated patient access to investigational drugs, while the drug or biological product is being tested in clinical trials. This will also be important for the CMT community as clinical trials for this disease are being launched.

Do You Have Charcot-Marie-Tooth Type 4 (CMT4)? – We Need Your Help

Autosomal recessive demyelinating CMT4 patients present with earlyonset and slowly progressing symptoms. These include progressive distally accentuated weakness and atrophy of muscles in the lower limbs. In addition, patients may have weakness and atrophy of hands, sensory loss and pes cavus (high-arched feet), and walking difficulties. Further information on CMT4 can be found at Orphanet.

Hot Off the Press – Potential Treatment for CMT1A

Two recent publications from Pharnext describe a novel synergistic combination of 3 drugs (baclofen, naltrexone and sorbitol) and its effect on CMT1A both in the lab and in a phase II clinical trial. These 3 drugs already approved but for unrelated conditions, are combined at new optimal lower doses and under a new formulation. This novel potential therapeutic is called PXT-3003.

Support CMT Therapeutic Alliance

HNF has entered into a joint venture – the CMT Therapeutic Alliance – with a unique non profit organization (BioPontis Alliance for Rare Diseases) that brings professional drug discovery capabilities to translate our research results into potential treatments.

Join the conversation

Leave a Comment

3 Comments

  1. Alice Suzanne

    I want to take this opportunity to inform HCP readers of the 10 year partnership I had with my doctor in trying to find a reason for the symptoms I was experiencing because I was very fortunate in that my doctor is a physician who is a healer…unlike many who are trained more as mechanics these days. Feel free to contact me if you should wish to ask a question about any aspect of my life as an undiagnosed CMT patient and how we finally found that I suffered from CMT. It is the least I can do to honor my doctor for persisting with me instead of writing me off as a hysterical female.

    Reply
    • Allison Moore

      Hi Alice,

      We would love to hear more about your experience and your HCP who didn’t give up and was persistent in helping you get to the cause of your symptoms. We would appreciate the HCP contact information to add to the HNF Healthcare Provider Directory.

      Thank you for posting!

      Reply
  2. jim

    It is an honor to be associated with such a great foundation. Planning to create some great content with HNF to bring awareness of CMT to a larger audience.

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news